What is the translation of " 转移性疾病 " in English?

• metastatic disease

Examples of using 转移性疾病 in Chinese and their translations into English

些没有表现出另一种主要肿瘤或转移性疾病。
Workup did not show another primary tumor or metastatic disease.

晚期的RCC包括转移性疾病和不能通过手术移除的局部晚期疾病。
Advanced RCC includes both metastatic disease and locally advanced disease that cannot be removed by surgery.

尽管在一项转移性疾病的单次试验中已经证明了总体生存效益很大，但在其他试验中没有发现类似的结果。
A large overall survival benefit has been demonstrated in a single trial in metastatic disease, but similar results have not been seen in other trials.

当器官得到转移性疾病时，它开始收缩，直到其淋巴结破裂或经历溶解。
When the organ gets a metastatic disease it begins to shrink until its lymph nodes burst, or undergo lysis.

这些细胞可以随时重新激活，并造成复发和转移性疾病的严重风险。
These cells can reactivate at anytime and pose a serious risk of recurrence and metastatic disease.

激酶抑制剂最初用于治疗已有的转移性疾病，但未能逆转其生长。
The kinase inhibitor was originally used to target pre-existing metastatic disease but failed to reverse its growth.

当他们检查这些数据时，研究人员发现在转移性疾病中MMP9水平升高。
While sifting through this data, the researchers noticed that MMP9 levels were elevated in metastatic disease.

手术减瘤术（减灭）被推荐为许多妇女卵巢癌的初始治疗，即使是那些与转移性疾病。
Surgical cytoreduction(debulking) is recommended as initial treatment for many women with ovarian cancer, even those with metastatic disease.

其中，1446名（94%）患者患有IV期或转移性疾病。
Of these, 1446(94%) of patients had stage IV or metastatic disease.

行全身计算机断层扫描（CT），排除转移性疾病[7]。
Pan-body computed tomography(CT) scan to rule out metastatic disease[7].

这些癌症生存率的停滞在很大程度上反映了复发和转移性疾病患者缺乏重大的治疗进展。
Stagnant survival rates for these cancers largely reflect a lack of major treatment advances for patients with recurrent and metastatic disease.

或ceritinib（Zykadia）作为第一种ALK抑制剂治疗转移性疾病。
Or ceritinib( Zykadia) is the first ALK inhibitor to treat metastatic disease.

手术是治疗的中流砥柱，但对于局部晚期或转移性疾病没有护理标准。
Surgery is the mainstay of treatment but there is no standard of care for locally advanced or metastatic disease.

在欧洲，胃癌每年影响约13万人，据估计40%患者会出现转移性疾病。
Gastric cancer in Europe affects approximately 130,000 people a year, and it is estimated that 40% of those patients will have metastatic disease.

由于大多数结直肠癌相关死亡是由转移性疾病引起的，因此确定导致转移的途径非常重要。
Because the majority of colorectal cancer-associated deaths are due to metastatic disease, identifying pathways that contribute to metastasis is of high importance.

方法::36ES患者转移性疾病≥18年见过从1977年至2007年在梅奥诊所的记录研究追溯了。
METHODS: The records of 36 ES patients with metastatic disease≥ 18 years seen from 1977 to 2007 at the Mayo Clinic were studied retrospectively.

共有108名患者(75名患有转移性疾病，33名患有局部晚期疾病)被纳入疗效评估。
A total of 108 patients(75 with metastatic disease and 33 with locally-advanced disease) were included in the efficacy evaluation.

我们可以使用ctDNA活检跟踪转移性疾病患者的治疗反应，从而为患者治疗带来积极的影响吗?
Can we use ctDNA to follow response to therapies in metastatic disease that actually makes a positive difference for patient care?

化学疗法是TNBC治疗的基石，可在手术前或手术后预防性使用，也可用于治疗转移性疾病。
Chemotherapy is the cornerstone of treatment for TNBC, used either prior to surgery or prophylactically after surgery, as well as for treatment of metastatic disease.

Dana-Farber/Brigham和妇女癌症中心的团队方法允许彻底讨论哪些转移性疾病患者应该手术切除转移瘤。
Dana-Farber/Brigham and Women's Cancer Center's team approach includes thorough discussions about which patients with metastatic disease should have surgical removal of metastases.

狗的癌症移动速度要快得多，超过90%的人在2年内死于转移性疾病。
The cancer moves much faster in dogs, with more than 90 percent succumbing to metastatic disease within 2 years.

其他人完全逃避通知，然后螺旋状无症状转为转移性疾病。
Others escape notice entirely, and then spiral without symptoms into metastatic disease.

事实上，它被广泛地估计，90％的癌症死亡是由于转移性疾病而不是原来的肿瘤。
In fact, it is widely estimated that 90% of cancer deaths are due to metastatic disease rather than the original tumor.

狗的癌症移动速度要快得多，超过90%的人在2年内死于转移性疾病。
Cancer moves much faster in dogs, with over 90% succumbing to metastatic disease within 2 years.

具体而言，Lorbrena（劳拉替尼）被批准用于克唑替尼（Xalkori）和至少另外1种ALK抑制剂治疗转移性疾病的患者;
Specifically, lolatinib is approved for the treatment of metastatic disease with xalkori and at least one additional ALK inhibitor;

Alectinib（Alecensa）作为第一种ALK抑制剂治疗转移性疾病;
Alectinib(Alecensa) as the first ALK inhibitor for the treatment of metastatic disease;

它专注于一个被诊断为局限性疾病但后来复发转移性疾病的女性亚组。
It focused on a subgroup of women who were diagnosed with localized disease but later relapsed with metastatic disease.

根据欧盟的统计，每年大约有2,500名欧洲人受到MCC的影响，转移性疾病被诊断为5-12%的MCC患者。
Approximately 2,500 Europeans are affected by MCC each year, with metastatic disease diagnosed in 5- 12% of patients with MCC.

狗的癌症移动速度要快得多，超过90%的人在2年内死于转移性疾病。
The cancer moves much faster in dogs, with more than 90% succumbing to metastatic disease within two years.